Richard E. Chaisson, MD

Chaisson headshot

Dr. Richard E. Chaisson is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in epidemiology and in international health, both in the Johns Hopkins Bloomberg School of Public Health. His area of clinical expertise is infectious diseases, particularly tuberculosis and HIV/AIDS.

Dr. Chaisson serves as the director of the Johns Hopkins University Center for Tuberculosis Research, the director and principal investigator of the Johns Hopkins Center for AIDS Research.

He received his B.S. and M.D. degrees from the University of Massachusetts. He was an intern, resident, fellow and assistant professor of medicine at the University of California, San Francisco, prior to moving to Johns Hopkins.

From 1988 to 1998 he was director of the Johns Hopkins AIDS Service, leading the inpatient Polk Service on Osler 8 and the outpatient Moore Clinic.  He was a pioneer in observational cohort studies of HIV and with his colleague Richard Moore co-founded the Johns Hopkins HIV Clinic cohort, a major contributor to the study of the outcomes of HIV disease and its treatment.  He founded the Center for TB Research which is the leading academic center for basic, clinical, applied, and epidemiologic investigations in TB and its control.

Dr. Chaisson has conducted multiple trials of treatments and strategies to treat, prevent, and control TB, TB/HIV co-infection, and HIV.  From 2002-2014 he led the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), a Gates Foundation-funded consortium that conducted population-level trials of TB control strategies in high-burden areas.  From 2011-2018 he was inaugural chair of the TB Transformative Science Group of the AIDS Clinical Trials Group, leading the development and implementation of a large portfolio of trials address TB treatment and preventive therapy.

Dr. Chaisson has been recognized with numerous honors, including election to the Association of American Professors in 2016, the Champions of TB Control Award from the U.S. Agency for International Development (USAID) in 2014 and the American Thoracic Society's World Lung Health Award in 2006.

Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally

Post Date: 
Chaisson headshot; USAID Awards Johns Hopkins Medicine, Partners, Up to $200 Million for Global TB R
To address the global burden of TB, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by USAID for the SMART4TB project.